Novo Integrated Sciences, Inc. (NVOS)

Market Cap	76.95K +30.0%
Revenue (ttm)	13.29M +5.7%
Net Income	-16.17M
EPS	-0.90
Shares Out	19.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0039
Previous Close	0.0039
Day's Range	0.0039 - 0.0039
52-Week Range	0.0001 - 0.0600
Beta	5.83
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Novo Integrated Sciences

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Robert Mattacchione
• Employees: 264
• Stock Exchange: OTCMKTS
• Ticker Symbol: NVOS

Financial Performance

In fiscal year 2024, Novo Integrated Sciences's revenue was $13.29 million, an increase of 5.75% compared to the previous year's $12.57 million. Losses were -$16.17 million, 22.3% more than in 2023.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 18, 2026

Data Sources Report a data error